The confidential portions of this exhibit have been filed separately with the Securities and Exchange Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities Exchange Act of 1934, as amended. REDACTED PORTIONS OF THIS EXHIBIT ARE MARKED BY AN ***.

This Fifth Amendment to the April 27, 2012 Supply Agreement (the “Fifth Amendment”) is made as of April 25, 2016 (the “Fifth Amendment Effective Date”) by and between Endo Ventures Limited, a company organized and existing under the laws of Ireland (registered number 442731) having its principal office at First Floor, Minerva House, Simmonscourt Road, Ballsbridge, Dublin 4, Ireland for itself and its Affiliates, each of which shall be bound by this Fifth Amendment as if each had separately executed this Fifth Amendment, (collectively “Endo”), and Noramco, Inc. a Georgia corporation having a principal place of business at 500 Swedes Landing Road, Wilmington, DE 19801, USA (“Noramco”) hereinafter collectively and/or individually (“Parties” and/or a “Party”).

WHEREAS:

NOW THE PARTIES HEREBY AGREE AS FOLLOWS:

“Term.    Unless sooner terminated pursuant to the terms hereof, the term of this Agreement shall commence on the Effective Date and shall continue until four (4) years from the Effective Date (the “Initial Term”). Thereafter, this Agreement automatically renews for additional terms of one (1) year each (each, a “Renewal Term” and together with the Initial Term, the “Term”), unless written notice of non-renewal is given by any Party to the other Party by no later than *** of the then­current Term; provided, however, that solely with respect to the

Renewal Term scheduled to commence on ***, notice of non-renewal for such Renewal Term may be provided by either Party no later than ***. For the purposes of clarity, in the event that either Party provides notice of non-renewal on or prior to ***, the Agreement will not renew for the Renewal Term commencing on ***.”